xCures
Summary active Updated Jun 24, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
xCures is an AI-driven healthcare technology company that extracts and standardizes clinical data from fragmented medical records to support clinical decision-making and research 12. The company was founded in 2018 as a spinout from Cancer Commons by Marty Tenenbaum and Jeff Shrager 23. Mika Newton serves as CEO 13.
By the time of its 2026 Series B, xCures had processed more than 300 million medical records from over 550,000 healthcare locations, and counted enterprise customers including Exact Sciences, Caris Life Sciences, and Novocure 12. The company reported 2025 ARR of approximately $10 million and projected 2026 ARR of $20 million or more 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-06-24 | Series B | $46M | Innovius Capital | iGrow, Spring Mountain Capital, existing backers 12 |
| 2023-12 | Series A | $25M | (not disclosed) | 1 |
The Series B brought total funding to more than $76 million and valued the company at $127 million post-money — more than double the valuation of the December 2023 Series A 1.
What Investors Say
No independently sourced investor quotes located at time of profile creation.
What Founders Say
CEO Mika Newton stated: “Healthcare has spent decades generating enormous amounts of patient data without a reliable way to make that information usable” 1.
Sources
-
Chris Metinko, “Exclusive: xCures Lands $46M Series B To Clean Up Messy Medical Records With AI,” Crunchbase News, June 24, 2026. Accessed June 2026. https://news.crunchbase.com/venture/xcures-lands-seriesb-medical-records-ai/↩↩↩↩↩↩↩↩
-
“xCures Raises $46 Million to Expand Platform That Converts Medical Records Into Usable Clinical Data,” citybiz, June 24, 2026. Accessed June 2026. https://www.citybiz.co/article/865242/xcures-raises-46-million-to-expand-platform-that-converts-medical-records-into-usable-clinical-data/↩↩↩↩
-
“xCures Closes $46 Million Series B Financing to Transform Fragmented Medical Records into Decision-ready Data through its Clinical Clarity Engine,” advfn (release), June 24, 2026. Accessed June 2026. https://uk.advfn.com/stock-market/share-news/xCures-Closes-46-Million-Series-B-Financing-to-Tr/98802928↩↩